[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HUP9903698A2 - A pentoxifyllin és az I-es típusú interferonok kombinált alkalmazása a szklerózis multiplex kezelésére - Google Patents

A pentoxifyllin és az I-es típusú interferonok kombinált alkalmazása a szklerózis multiplex kezelésére

Info

Publication number
HUP9903698A2
HUP9903698A2 HU9903698A HUP9903698A HUP9903698A2 HU P9903698 A2 HUP9903698 A2 HU P9903698A2 HU 9903698 A HU9903698 A HU 9903698A HU P9903698 A HUP9903698 A HU P9903698A HU P9903698 A2 HUP9903698 A2 HU P9903698A2
Authority
HU
Hungary
Prior art keywords
multiple sclerosis
pentoxifylline
interferons
type
combination
Prior art date
Application number
HU9903698A
Other languages
English (en)
Inventor
Peter Rieckmann
Original Assignee
Dr. Rentschler Arzneimittel Gmbh & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Rentschler Arzneimittel Gmbh & Co. filed Critical Dr. Rentschler Arzneimittel Gmbh & Co.
Publication of HUP9903698A2 publication Critical patent/HUP9903698A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány a heveny fellőbbanásős és a másődlagősan prőgrediálószklerózis műltiplex kőmbinált kezelésére vőnatkőzik. A kőmbináltkezelés I-es típűsú interferőnők szűbkűtán vagy intraműszkűlárisadagőlásával és a Pentőxifyllin egyidejű perőrális alkalmazásávaltörténik, mely űtóbbi adőtt esetben késleltetett hatású lehet. ŕ
HU9903698A 1995-11-30 1996-11-08 A pentoxifyllin és az I-es típusú interferonok kombinált alkalmazása a szklerózis multiplex kezelésére HUP9903698A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19544768A DE19544768C1 (de) 1995-11-30 1995-11-30 Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose
PCT/EP1996/004906 WO1997019686A1 (de) 1995-11-30 1996-11-08 Verwendung einer kombination aus pentoxifyllin mit typ i-interferonen zur behandlung der multiplen sklerose

Publications (1)

Publication Number Publication Date
HUP9903698A2 true HUP9903698A2 (hu) 2000-03-28

Family

ID=7778885

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903698A HUP9903698A2 (hu) 1995-11-30 1996-11-08 A pentoxifyllin és az I-es típusú interferonok kombinált alkalmazása a szklerózis multiplex kezelésére

Country Status (7)

Country Link
EP (1) EP0863759A1 (hu)
JP (1) JP2000501085A (hu)
CA (1) CA2238770A1 (hu)
DE (1) DE19544768C1 (hu)
HU (1) HUP9903698A2 (hu)
NO (1) NO982463L (hu)
WO (1) WO1997019686A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP823999A0 (en) * 1999-01-20 1999-02-11 University Of Queensland, The A treatment
WO2007041506A1 (en) * 2005-10-03 2007-04-12 Melior Discovery, Inc. Purine formulations and methods for managing disorders
US20090239886A1 (en) 2008-02-29 2009-09-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
MX2012002704A (es) 2009-09-02 2012-03-21 Concert Pharmaceuticals Inc Derivados de xantina sustituidos.
WO2012031138A2 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
US20140296263A1 (en) 2011-07-19 2014-10-02 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP2836492B1 (en) 2012-04-13 2018-03-14 Concert Pharmaceuticals Inc. Substituted xanthine derivatives
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione
US20170216296A1 (en) 2014-04-18 2017-08-03 Concert Pharmaceuticals, Inc. Methods of treating hyperglycemia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU538186B2 (en) * 1980-03-07 1984-08-02 Scotia Holdings Plc Prostaglandin precursors
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US5763446A (en) * 1992-03-26 1998-06-09 University Of Southern California Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases
GB9218810D0 (en) * 1992-09-04 1992-10-21 Univ Birmingham Antiviral pyrimidine nucleosides
DE4343034C1 (de) * 1993-12-16 1995-06-08 Rentschler Arzneimittel Verwendung von Pentoxifyllin zur Behandlung von Multipler Sklerose

Also Published As

Publication number Publication date
NO982463D0 (no) 1998-05-29
JP2000501085A (ja) 2000-02-02
WO1997019686A1 (de) 1997-06-05
CA2238770A1 (en) 1997-06-05
DE19544768C1 (de) 1997-07-10
EP0863759A1 (de) 1998-09-16
NO982463L (no) 1998-05-29

Similar Documents

Publication Publication Date Title
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
CY1107314T1 (el) Μεθοδος θεpαπευτικης αγωγης ασθενων προσβεβλημενων με σκληρυνση κατα πλακας χρησιμοποιωντας συναινετικη ιντepφepονη
NO983284L (no) Anvendelse av et anti-faktor 1X monoklonalt antistoff og en nukleinsyre som koder for et monoklonalt antistoff for fremstilling av et medikament for behandling av trombose- og emboli-assosierte lidelser.
UA111707C2 (uk) Застосування виділеного анти-tnf-альфа антитіла людини
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
NL300179I1 (nl) Geneesmiddelvoorlopers van trombineremmers.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE219373T1 (de) Medikamente zur behandlung von autoimmunerkrankungen mit interferon-tau
ZA966744B (en) Pharmaceutical composition.
DE69625769D1 (de) Verteiler zur unabhängigen Ein- und/oder Abführung von Fluiden
HUP9903698A2 (hu) A pentoxifyllin és az I-es típusú interferonok kombinált alkalmazása a szklerózis multiplex kezelésére
ATE223431T1 (de) Derivate von dolastatin, dreen herstellung un verwendung
NO975234L (no) Fremgangsmåte for behandling av maniske og bipolare forstyrrelser
DE69624243D1 (de) Verwendung von unverdaulichen oligosacchariden zur vorbeugung und behandlung von mittelohrentzündung bei menschen
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
ZA947783B (en) Method of treating depressed reticuloendothelial system function
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
HUP9901183A2 (hu) Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére
BR9612549A (pt) Método para tratamento de agressão excessiva
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
YU40098A (sh) Upotreba olanzapina za dobijanje leka